4682 related articles for article (PubMed ID: 3994311)
1. Immune functions in melanoma patients during treatment with interferon [HuIFN-alpha (Le)] alone or in combination with cimetidine.
Flodgren P; Malmström P; Axelsson B; Boketoft A; Borgström S; Sjögren HO
Anticancer Res; 1985; 5(2):197-204. PubMed ID: 3994311
[TBL] [Abstract][Full Text] [Related]
2. Influence in vitro on NK and K cell activities by cimetidine and indomethacin with and without simultaneous exposure to interferon.
Flodgren P; Sjögren HO
Cancer Immunol Immunother; 1985; 19(1):28-34. PubMed ID: 3844972
[TBL] [Abstract][Full Text] [Related]
3. Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of the treatment on immunological functions.
Kellokumpu-Lehtinen P; Nordman E; Toivanen A
Cancer Immunol Immunother; 1989; 28(3):213-7. PubMed ID: 2784356
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of advanced malignant melanoma with coumarin and cimetidine. A phase II study.
Pedersen L; Rose C; Langvad E
Cancer Immunol Immunother; 1987; 24(2):178-9. PubMed ID: 3829053
[TBL] [Abstract][Full Text] [Related]
5. [Preoperative ultrasonographic measurement of melanoma thickness with 20 MHz probe].
Pennasilico G; Santini A; Bono R; Cacciaguerra MG; Puddu P; Falappa P
Radiol Med; 1994 Oct; 88(4):388-91. PubMed ID: 7997609
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic characterization of tumor infiltrating lymphocytes and peripheral blood lymphocytes isolated from melanomatous and non-melanomatous Sinclair miniature swine.
Morgan CD; Measel JW; Amoss MS; Rao A; Greene JF
Vet Immunol Immunopathol; 1996 Dec; 55(1-3):189-203. PubMed ID: 9014317
[TBL] [Abstract][Full Text] [Related]
8. Acral lentiginous melanoma.
Sutherland CM; Mather FJ; Muchmore JH; Carter RD; Reed RJ; Krementz ET
Am J Surg; 1993 Jul; 166(1):64-7. PubMed ID: 8328633
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic interventions for cancer.
Nabel GJ; Nabel EG; Yang Z; Fox BA; Plautz GE; Gao X; Huang L; Shu S; Gordon D; Chang AE
Cold Spring Harb Symp Quant Biol; 1994; 59():699-707. PubMed ID: 7587133
[No Abstract] [Full Text] [Related]
10. Novel cytotoxic 3'-(tert-butyl) 3'-dephenyl analogs of paclitaxel and docetaxel.
Ali SM; Hoemann MZ; Aubé J; Mitscher LA; Georg GI; McCall R; Jayasinghe LR
J Med Chem; 1995 Sep; 38(19):3821-8. PubMed ID: 7562913
[TBL] [Abstract][Full Text] [Related]
11. A characterization of the activity of alpha-1,3,5-triglycidyl-s-triazinetrione, a novel antineoplastic compound.
Spreafico F; Atassi G; Filippeschi S; Malfiore C; Noseda S; Boschetti D
Cancer Chemother Pharmacol; 1980; 5(2):103-8. PubMed ID: 7471313
[TBL] [Abstract][Full Text] [Related]
12. Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro.
Aubert C; Rougé F; Galindo JR
J Natl Cancer Inst; 1980 May; 64(5):1029-40. PubMed ID: 6929009
[TBL] [Abstract][Full Text] [Related]
13. Cell detachment and metastasis.
Weiss L; Ward PM
Cancer Metastasis Rev; 1983; 2(2):111-27. PubMed ID: 6352010
[TBL] [Abstract][Full Text] [Related]
14. Experimental metastasis correlates with cyclic AMP accumulation in B16 melanoma clones.
Sheppard JR; Koestler TP; Corwin SP; Buscarino C; Doll J; Lester B; Greig RG; Poste G
Nature; 1984 Apr 5-11; 308(5959):544-7. PubMed ID: 6323999
[TBL] [Abstract][Full Text] [Related]
15. Melanosome and lysosome. II. Digestion of melanosome with mouse liver lysosome.
Otaki N
Bull Tokyo Med Dent Univ; 1970 Sep; 17(3):179-86. PubMed ID: 5273194
[No Abstract] [Full Text] [Related]
16. Study of S91 mouse melanomas by electron paramagnetic resonance spectroscopy and tissue culture. I. The effect of cysteine on blue light signals and on growth in vitro.
Duke PS; Landgraf W; Mitamura AE; Demopoulos HB
J Natl Cancer Inst; 1966 Aug; 37(2):191-8. PubMed ID: 4287952
[No Abstract] [Full Text] [Related]
17. [Differentiation of B16 melanoma cells induced by ginsenoside RH2].
Xia LJ; Han R
Yao Xue Xue Bao; 1996; 31(10):742-5. PubMed ID: 9863241
[TBL] [Abstract][Full Text] [Related]
18. Is the capacity for lymph node-mediated distant dissemination the same for all nodal groups in malignant melanoma?
Karakousis CP; Balch CM; Bartolucci A; Driscoll DL
Melanoma Res; 1998 Oct; 8(5):419-24. PubMed ID: 9835455
[TBL] [Abstract][Full Text] [Related]
19. The expression of C-myb in human metastatic melanoma cell lines and specimens.
Walker MJ; Silliman E; Dayton MA; Lang JC
Anticancer Res; 1998; 18(2A):1129-35. PubMed ID: 9615777
[TBL] [Abstract][Full Text] [Related]
20. Clinical management and current research in isolated limb perfusion for sarcoma and melanoma.
Hohenberger P; Kettelhack C
Oncology; 1998; 55(2):89-102. PubMed ID: 9499194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
